H. NidaSenMDMHSc

Clinical Trials

• Rituximab for Autoimmune Retinopathy Start of enrollment: 2010 Jan 22

  Completed

  Phase 1

• Immunogenetic Mechanisms in Behcet's Disease Start of enrollment: 2010 Apr 15

  Terminated

• Microplasmin Intravitreal Administration in Participants With Uveitic Macular Edema Start of enrollment: 2011 Jan 01

  Terminated

  Phase 1, Phase 2

• Treatment of Non-infectious Intermediate and Posterior Uveitis Associated Macular Edema With Intravitreal Methotrexate Start of enrollment: 2011 Feb 01

  Terminated

  Phase 1, Phase 2

• Topical Interferon Gamma for Macular Edema Secondary to Uveitis Start of enrollment: 2011 Jun 01

  Completed

  Phase 1, Phase 2

• Sirolimus Injections for Autoimmune Scleritis Start of enrollment: 2012 Jan 01

  Completed

  Phase 1, Phase 2

• Ustekinumab for Active Sight-Threatening Uveitis Start of enrollment: 2012 Jul 03

  Withdrawn

  Phase 1, Phase 2

• Gevokizumab for Active Scleritis Start of enrollment: 2013 Mar 01

  Completed

  Phase 1, Phase 2

• Ustekinumab (STELARA) for the Treatment of Active Sight-Threatening Uveitis (STAR Study) Start of enrollment: 2017 Mar 30

  Completed

  Phase 2

• Join now to see all